CTRP3调控SeVGMT重编程心脏纤维母细胞为心肌样细胞的机制
DOI:
作者:
作者单位:

1.延安大学附属医院心血管中心;2.延安大学附属医院病理科;3.延安大学附属医院骨科

作者简介:

通讯作者:

中图分类号:

基金项目:

国家自然科学基金(编号:81960080);国家自然科学基金(编号:81760069)


Mechanism of CTRP3 regulating SeVGMT to reprogram cardiac fibroblasts into induced cardiomyocyte-like cells
Author:
Affiliation:

1.Cardiovascular Center, Department of Pathology, Department of Orthopedics,Yanan University Affiliated Hospital,Yanan Shaanxi;2.Yanan University Affiliated Hospital

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 探究C1q肿瘤坏死因子相关蛋白3(CTRP3)调控仙台病毒(SeV)载体过表达Gata4、Mef2c和Tbx5(SeVGMT)重编程心脏纤维母细胞(CFs)为心肌样细胞(iCMs)的效率及作用机制。方法 将CFs分为Control组、NC-Lv组、CTRP3-Lv组、NC-sh组和CTRP3-sh组。使用Lipofectamine 3000试剂将NC-Lv、CTRP3-Lv、NC-sh和CTRP3-sh转染至CFs,转染48 h。然后将Lipofectamine 3000试剂与SeVGMT混合并在室温下孵育48 h,更换培养基后继续培养21 d。显微镜下观察不同培养时间点(0、3、7、14、21 d)的细胞形态。通过细胞免疫荧光、qRT-PCR和Western blot检测不同时间点的心肌特异性蛋白α-MHC、α-actin、cTnT、Cx43、Actc1和Myh6的表达,并计算不同时间点的跳动细胞比例。结果 随着培养时间的延长,各组CFs中α-MHC、α-actin、cTnT、Cx43、Actc1和Myh6的相对荧光强度、mRNA和蛋白水平均升高(P<0.05),并且培养14 d时的上述心肌特异性蛋白的表达水平较培养7 d时大幅度升高(P<0.05)。培养3 d、7 d、14和21 d时,与NC-Lv组比较,CTRP3-Lv组CFs中α-MHC、α-actin、cTnT、Cx43、Actc1和Myh6的相对荧光强度、mRNA和蛋白水平升高(P<0.05)。与NC-sh组比较,CTRP3-sh组CFs中α-MHC、α-actin、cTnT、Cx43、Actc1和Myh6的相对荧光强度、mRNA和蛋白水平均降低(P<0.05)。培养7 d时,各组CFs中出现跳动细胞,随着培养时间的延长,各组CFs中的跳动细胞比例升高(P<0.05),并且培养14 d时的跳动细胞比例较培养7 d时大幅度升高(P<0.05)。培养7 d、14和21 d时,与NC-Lv组比较,CTRP3-Lv组CFs中的跳动细胞比例升高(P<0.05)。与NC-sh组比较,CTRP3-sh组CFs中的跳动细胞比例降低(P<0.05)。结论 CTRP3可增强SeVGMT重编程CFs为iCMs。

    Abstract:

    Objective To reveal the efficiency and mechanism of C1q tumor necrosis factor-related protein 3 (CTRP3) regulating Sendai virus (SeV) vector overexpression of Gata4, Mef2c and Tbx5 (SeVGMT) to reprogram cardiac fibroblasts (CFs) into induced cardiomyocyte-like cells (iCMs). Methods CFs were divided into Control group, NC-Lv group, CTRP3-Lv group, NC-sh group and CTRP3-sh group. NC-Lv, CTRP3-Lv, NC-sh and CTRP3-sh were transfected into CFs using Lipofectamine3000 reagent for 48 h. Then Lipofectamine3000 reagent was mixed with SeVGMT and incubated at room temperature for 48 h. The culture medium was replaced and then cultured for 21 d. The cell morphology at different culture time points (0, 3, 7, 14, 21 d) was observed under a microscope. The expression of myocardial specific proteins α-MHC, α-actin, cTnT, Cx43, Actc1 and Myh6 at different time points were detected by cell immunofluorescence, qRT-PCR and Western blot, and the proportion of beating cells at different time points was calculated. Results With the extension of culture time, the relative fluorescence intensity, mRNA and protein levels of α-MHC, α-actin, cTnT, Cx43, Actc1 and Myh6 in CFs of each group increased (P<0.05), and the expression levels of the above myocardial specific proteins at 14 d of culture were significantly higher than those at 7 d of culture (P<0.05). At 3 d, 7 d, 14 d and 21 d of culture, the relative fluorescence intensity, mRNA and protein levels of α-MHC, α-actin, cTnT, Cx43, Actc1 and Myh6 in CFs of CTRP3-Lv group increased compared with those of NC-Lv group (P<0.05). Compared with the NC-sh group, the relative fluorescence intensity, mRNA and protein levels of α-MHC, α-actin, cTnT, Cx43, Actc1 and Myh6 in CFs of the CTRP3-sh group were decreased (P<0.05). At 7 d of culture, beating cells appeared in CFs of each group. With the extension of culture time, the proportion of beating cells in CFs of each group increased (P<0.05), and the proportion of beating cells at 14 d of culture was significantly higher than that at 7 d of culture (P<0.05). At 7 d, 14 d and 21 d of culture, compared with the NC-Lv group, the proportion of beating cells in CFs of the CTRP3-Lv group increased (P<0.05). Compared with the NC-sh group, the proportion of beating cells in CFs of the CTRP3-sh group decreased (P<0.05). Conclusion CTRP3 can enhance SeVGMT reprogramming of CFs into iCMs.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2025-02-27
  • 最后修改日期:2025-06-01
  • 录用日期:2025-07-23
  • 在线发布日期:
  • 出版日期: